Back to Search

TGTX

TG Therapeutics, Inc.
Data: 2026-08-03
$46.17
Price
-11.26%
Change
$59.30
52W High
$25.28
52W Low
Full AI Analysis Buy/Sell Forecast Trendline Why Moving Charts Options

TG Therapeutics Inc is a fully integrated, commercial-stage, biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases. The company has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS). In addition, it is developing TG-1701 (BTK inhibitor), Azer-Cel (allogeneic CD19 CAR T), and TG-1801 (anti-CD47/CD19 bispecific mAb) for B-cell disorders, which are under Phase 1 trials. Geographically, the company generates a majority of its revenue selling BRIUMVI in the United States, with the rest coming from sales in other countries.

Quick Stats
Aug 03, 2026

59.5

AI Score

HOLD

2.5

Volume Ratio

Aug 03, 2026

Next Earnings

10

+ve Days (30d)

20

-ve Days (30d)

TGTX Stock Summary

Last updated Aug 03, 2026

TGTX is currently trading at $46.17, positioned above its 200-day moving average of $36.74, indicating a long-term uptrend. The stock has a 52-week range of $25.28 to $59.3.

Technical Analysis: The 50-day moving average stands at $50.05, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 31.732, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.177, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates TGTX at 59.5/100 with a HOLD recommendation.

TGTX (TG Therapeutics, Inc.) Indicators

Last updated Aug 03, 2026

Indicator Value
RSI(14) 31.732
CMF (20) -0.177
ROC (10) -14.39
ADX (14) 23.415
Indicator Value
MACD (12,26,9) -0.021
AROONOSC (14) -35.714
WILLAMS %R (14) -97.557
MFI (14) 24.104
TGTX Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

TGTX Price vs Max Options Open Interest
TGTX Max Change In Options Open Interest

TGTX Options - Sort by Max open Interest (near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

TGTX Daily Out of Money Options - Sort by Max open Interest (near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

TGTX Daily In the Money Options - Sort by Max open Interest (near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

TGTX Most Active Options by Volume(near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI		 Ask PC Delta Vega Volatility % change Track

TG Therapeutics, Inc. is above the 200 Day SMA but below the 50 Day SMA — long-term uptrend intact but under near-term pressure (Mixed).

TGTX Moving Averages Analysis

TG Therapeutics, Inc. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Aug 03, 2026

TGTX (TG Therapeutics, Inc.) Simple Moving Averages

Moving Averages are last updated Aug 03, 2026

Days MA
10 53.4
20 54.78
30 54.66
50 50.05
100 42.5
200 36.74

TGTX Fundamental Analysis

P/E (Forward) 56.8182
P/E (Trailing) 18.7168
Market Cap ($) 8.2 billion
Earnings/Share ($) 2.86
Net Profit Margin (%) 0.6595
Dividend/Share ($) --
EPS Estimate Current Year ($) 1.5724
EPS Estimate Next Year ($) 3.2811
WallStreet Target Price ($) 68.43
Most Recent Quarter